Companies
The latest research, products, and discoveries from the science industry’s leading companies and company divisions.
Cannabis compliance is often confusing and always complex. Whether our clients are starting a cannabis business, are unsure of risky pitfalls, or are in need mitigating legal vulnerabilities, we make the difference in actually being compliant. We also support governments, developing, implementing, and managing cannabis regulatory models.
When it comes to cannabis policy, regulation, and operational compliance, our staff has the experience and insight to effectively implement excellence in the industry. Our solutions help our clients validate compliance and operate with peace of mind.
The Institute recognises and supports the benefits of using animals in research. Its members strongly believe that excellence in animal care and welfare goes hand in hand with excellence in science.
In 1985 a Register of Animal Technicians was established to emphasise the Institute's position regarding the ethical and legal aspects of care of laboratory animals. Many members of the Register, who are bound by a Code of Ethics, are named under the Animals (Scientific Procedures) Act 1986 as the Named Animal Care & Welfare Officer (NACWO) they are responsible for the care of all animals in designated establishments.
The IAT actively support the three R's - Refinement, Reduction & Replacement. We have expertise in our membership that are able to advise on all aspects of Animal welfare and technology.
We work closely with Animal Welfare organisations to promote best practice and draft guidelines on the care of all laboratory species including rodents, dogs, primates, farm animals, birds and fish.
For 20 years, IBL America has provided high quality laboratory reagent assays for research and clinical testing in various areas including autoimmunity, endocrinology, infectious disease, oncology and neuroscience. Due to our long-standing qualified domestic and international manufacturing partners, we provide you top quality:
ELISA kits
RIA kits
Chemiluminescent diagnostic and research tools
Antibodies
Proteins
Choosing IBL America means you will experience our internal, highly qualified, and knowledgeable technicians when you need them. IBL also can analyze any of the products we provide with our modern, fully-equipped internal laboratory. You can also receive laboratory testing services for routine diagnostics in addition to contractual research services.
IBL America is committed to providing you with quality products and professional service. Whether you are ordering our product or talking to one of our technical service representatives, our staff is dedicated to giving you the attention that you want and deserve. You, as our customer, are our only reason for business. Without you, we would not exist. We appreciate your business and we will continue to show our appreciation by our professional, friendly, and efficient service
Illumina is transforming human health as the global leader in sequencing and array-based technologies. Illumina's flexible and scalable sequencing systems support and enable a wide range of single-cell sequencing applications, from low-throughput deep interrogation of rare cell populations to high-throughput profiling of tissues. For more information, please visit www.illumina.com.
ImmunoChemistry Technologies, LLC provides quality laboratory services and research reagents. As a contract service laboratory, ICT specializes in custom immunoassay development, manufacturing, conjugation, lyophilization, and consulting services. ICT is focused on ELISA development and has the knowledge to develop reliable, sensitive, and specific tests. ICT offers a line of ELISA diluents including coat buffers, conjugate stabilizers, and sample diluents designed to reduce backgrounds, increase the specific signal, and improve the stability and shelf-life of the ELISA. ICT also offers a line of fluorescent reagents to measure caspase activity, apoptosis, and cell death in vitro.
Indivumed is an integrated oncology company leveraging its leading oncology biorepository expertise with its pre-clinical, clinical and diagnostic laboratory expertise aiming to develop individualized cancer therapies.
Indivumed provides products and services to obtain an in-depth understanding of the underlying mechanisms of a patients cancer and addresses several important demands in translational research and molecular diagnostics to support the implementation of personalized healthcare.
Indivumed offers a unique combination of capabilities which can significantly contribute to the identification of new biomarkers and drug targets, to the development of novel companion diagnostics to guide treatment decisions, to the collection of information for defining the right treatment for every patients unique biology, and ultimately to the cure of cancer.
Innova Biosciences are world leading experts in easy-to-use, cutting-edge bioconjugation technologies and services. The Company has the flexibility to support scientists from academia through to commercial manufacturing, developing and supplying reagent products to make science easier, both off-the shelf and to customer specification. Innova's products are based on its antibody and protein labeling, gold nanoparticle and latex conjugation, and oligonucleotide labeling technologies.
All of Innova Biosciences' product ranges are of the highest quality and are designed to streamline R&D and manufacturing processes, whilst also reducing overall project costs by cutting costs associated with material waste, in-house equipment and staff time, providing increased return on investment compared to traditional methods.
Innova Biosciences' offer their expanding portfolio, including the Lightning-Link®, InnovaCoat® and Thunder-Link® brands, as well as their custom services, to research laboratories, pharmaceutical, biotechnology and diagnostic companies worldwide.
Inscripta is developing the world's first benchtop platform for scalable digital genome engineering. The company's advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of single cells at an unprecedented scale. Inscripta's goal is to empower scientists whose gene editing research is stifled by current technical and licensing limitations. By providing this unique platform and engaging in collaborative business practices, such as making its MAD7™ CRISPR nuclease free for research and development purposes, the company enables scientists to realize a new era of biological discovery. Headquartered in Boulder, Colo., with offices in Pleasanton, Calif., and San Diego, Inscripta is backed by leading investors including Venrock, Foresite, Paladin Capital Group, Mérieux Développement, NanoDimension, MLS Capital, JS Capital Management LLC, and Oak HC/FT. For more information, visit www.inscripta.com.
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace.
InSphero provides 3D cell culture technology and tumor microtissue screening services for the cancer research industry. Our assay-ready 3D InSight™ Tumor Microtissues, scaffold-free GravityPLUS™ Hanging Drop System and GravityTRAP™ ULA Plates, 3D optimized assays, and SCREEN Cell3iMager enable more relevant & predictive in vitro efficacy testing and phenotypic screening.
The ICFA is a broad group of Cannabis farmers, scientists, and stakeholders working together to promote the unique quality and ecological benefits of traditionally farmed Cannabis and Cannabis-derived products while preserving the heritage of traditional farming communities.
Internationally, regulatory frameworks often require that therapeutic Cannabis varietals be grown indoors or in all season greenhouses despite the overwhelming evidence that traditionally farmed sun grown Cannabis is qualitatively and ecologically superior. This public policy trend has devastating environmental implications and leaves both patients and adult-use consumers without access to traditionally farmed sun grown cannabis and cannabis-derived products.
We have formed the International Cannabis Farmers Association to establish the science, data and consumer direct education necessary to break down these barriers while promoting the health and environmental benefits of traditionally farmed sun grown Cannabis.
As individuals, our power is limited. As a group, we are far more powerful.
